Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Interest Expenses (2016 - 2020)

Historic Interest Expenses for Avadel Pharmaceuticals (AVDL) over the last 7 years, with Q4 2020 value amounting to $3.3 million.

  • Avadel Pharmaceuticals' Interest Expenses rose 369.91% to $3.3 million in Q4 2020 from the same period last year, while for Sep 2021 it was $3.3 million, marking a year-over-year decrease of 6584.76%. This contributed to the annual value of $10.8 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Interest Expenses of $3.3 million as of Q4 2020, which was up 369.91% from $3.3 million recorded in Q3 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Interest Expenses ranged from a high of $3.3 million in Q4 2020 and a low of $175000.0 during Q1 2016
  • Its 5-year average for Interest Expenses is $1.8 million, with a median of $3.0 million in 2018.
  • Its Interest Expenses has fluctuated over the past 5 years, first crashed by 37.88% in 2017, then soared by 105779.47% in 2018.
  • Avadel Pharmaceuticals' Interest Expenses (Quarter) stood at $261000.0 in 2016, then increased by 0.77% to $263000.0 in 2017, then soared by 1057.79% to $3.0 million in 2018, then rose by 4.76% to $3.2 million in 2019, then grew by 3.7% to $3.3 million in 2020.
  • Its Interest Expenses stands at $3.3 million for Q4 2020, versus $3.3 million for Q3 2020 and $3.2 million for Q2 2020.